Ekta Aggarwal

Principal Account Manager

John Bell

CEO-Founder

Aaron Bell

Director, Google Research

Brendan Bulik-Sullivan

General Partner

Terri Burns

Partner

Brad Calder

VP and GM, Google Cloud Platform and Technical Infrastructure

Sumiran Das

Growth Equity Investor at Google Capital

Jamal Eason

Director of Product Management

Karim Faris

General Partner

Jacquelline Fuller

President

Raj Gajwani

Director, Orion Wifi @ Google Area 120

Margaret Georgiadis

President, Americas

Carletta Higginson

Director, Global Head of Music Publishing

Crystal Huang

Partner

Rahul Jain

Lead, Venture Capital and Startups - Google Cloud

Aftab Jutt

CEO

Sushrut Karanjkar

Director

David Krane

Mnaging Partner

Jess Kuizon

CEO

Skye Lee

Director of UX

Bibiana Leite

Director, Scaled Partnerships

Anthony Nakache

Managing Director, Google MENA

David Reshef

Venture Partner

Issi Rozen

Venture Partner

Philipp Schindler

Senior Vice President and Chief Business Officer

Aparna Sinha

Director, Product Management for Kubernetes and Anthos

Andrew R. Whalley

Director, Chrome Security

Andy Wheeler

General Partner

LightRoom Premium Mod APK Download Android

CEO

Co khi Nhan Do

CEO

Past deals in Growth Stage

Push Security

Series B in 2025
Push Security specializes in cybersecurity software that aims to prevent identity-based attacks. Its browser-based agent monitors how employees create and use identities, generating unique telemetry that can be accessed through the Push platform or integrated with existing security information and event management (SIEM) systems. This allows security teams to oversee their entire identity attack surface and effectively detect and block various identity-based threats, including advanced phishing techniques. Push Security enforces preventive measures that guide employees within their browser, helping to avert potential breaches before they occur. The platform also provides clear guidance for implementing essential security controls, with automation facilitating quicker deployment. This approach enables organizations, particularly small and medium-sized enterprises, to enhance their security measures efficiently and affordably without the need for additional solutions.

Omni

Series B in 2025
Omni is a multifaceted company based in San Francisco, California, that specializes in business intelligence, cybersecurity, and cloud engineering services. Its primary offering is a unique business intelligence platform that merges the reliability of a shared data model with the flexibility of SQL, allowing users to easily access, explore, and share curated data metrics. This platform is designed to streamline the data analytics process, enabling clients to focus on deriving meaningful insights without the complications often associated with data management. Additionally, Omni operates a rentals platform that connects local businesses with community members, providing access to a variety of rental items such as bikes, surfboards, and camping equipment. This initiative enhances community engagement by making diverse products readily available for short-term use.

Blockaid

Series B in 2025
Blockaid is a technology company that specializes in digital security. It develops a security platform designed to safeguard users from fraud, phishing, and hacks. The company employs a range of security features, including blockchain technology, to ensure the safety and security of users' data. This enables online businesses to offer their services with confidence, knowing that their customers' data is protected.

Sardine

Series C in 2025
Sardine is a financial technology company that specializes in providing a risk and fraud infrastructure tailored for the online economy. It has developed a device intelligence platform that leverages artificial intelligence and advanced risk engine software. This platform enhances fraud detection while minimizing sign-up friction by analyzing multiple real-time data points, including device information, browser details, and behavioral biometrics. By integrating this technology, Sardine enables businesses to establish a robust risk and fraud management framework, ultimately reducing costs within the fintech ecosystem.

Allara Health

Series B in 2025
Allara is a healthcare program focused on providing specialized virtual care for women dealing with complex chronic health conditions, particularly polycystic ovary syndrome. The platform connects patients with medical providers and registered dietitians, offering a comprehensive approach that includes diagnostic testing, prescriptions, and personalized video consultations. Allara emphasizes holistic care, integrating dietary and lifestyle changes alongside nutrition counseling to help women manage their health effectively. Through its virtual appointments, the program aims to simplify access to expert care, enabling patients to track and improve their overall medical wellbeing.

Leyden Labs

Series B in 2025
Leyden Labs is a biotechnology company focused on developing intranasal products aimed at protecting individuals from respiratory viruses. By targeting commonalities among various viral families, Leyden Labs seeks to provide broad-spectrum protection against multiple strains of viruses, including those in the influenza and coronavirus families. Unlike traditional vaccines that typically address specific variants, Leyden Labs' innovative approach allows for simultaneous protection against a range of viruses, thereby empowering individuals to safeguard their health and prevent the transmission of diseases. The company's team comprises experienced biotechnology professionals and new talent, all committed to advancing solutions that alleviate the impact of respiratory infections on global health.

Cala Health

Series C in 2024
Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.

Roboflow

Series B in 2024
Roboflow, Inc. is a software-as-a-service company focused on enhancing computer vision capabilities for software engineers. Founded in 2019 and based in Des Moines, Iowa, Roboflow offers solutions such as Roboflow Organize, which assists developers in managing image datasets and annotations, and Roboflow Pro, designed to facilitate the deployment of computer vision applications using existing engineering resources. The company's tools streamline the creation and organization of datasets, including both image and video data, and employ pre-trained models and artificial intelligence to automate the annotation process. By providing features like dataset management, image transformations, and easy integration, Roboflow enables teams to build computer vision models more efficiently, improving accuracy and reducing common errors that can hinder model performance.

Vitara Biomedical

Series B in 2024
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Metsera

Series B in 2024
Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.

PeopleOne Health

Series B in 2024
PeopleOne Health specializes in providing comprehensive healthcare solutions that integrate treatment and prevention, leading to substantial cost savings for both employers and employees. By focusing on value-based primary care, the company enables employers to save up to 30% on healthcare expenses while improving employee recruitment and retention. Employees benefit from an award-winning health program at no cost, which includes access to a dedicated team of top-tier healthcare professionals. PeopleOne Health designs and implements tailored corporate wellness programs for medium and large organizations, empowering employees to manage their health risks and stay informed about wellness opportunities. The company's commitment to customer satisfaction is reflected in an impressive net promoter score exceeding 90, significantly higher than the healthcare industry average.

Infinitus Systems

Series C in 2024
Infinitus Systems is an AI healthcare company focused on automating phone-based processes to enhance efficiency within the healthcare ecosystem. By streamlining tedious and time-consuming communication tasks, Infinitus aims to improve access to therapy, adherence, and affordability for patients. The company's innovative tool allows users to submit call requests easily, track updates, and receive notifications upon task completion. Infinitus Systems has raised $51.4 million in funding from prominent investors, including Kleiner Perkins, Coatue, and Google Ventures. Through its automation solutions, the company seeks to reduce the complexity and costs associated with back-office administration in the healthcare sector.

Scope3

Series B in 2024
Scope3 operates a supply chain emissions data platform that provides accurate and comprehensive emissions data to assist companies in integrating sustainability into their business decisions. The company develops models that outline the core inputs and outputs for products and services within the supply chain, enabling organizations to design more sustainable systems. Additionally, Scope3 prepares monthly sustainability reports that offer updated emissions data, allowing businesses to swiftly adapt to external changes and recognize their efforts in reducing carbon footprints.

Dandelion Energy

Series C in 2024
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Mechanical Orchard

Series B in 2024
Mechanical Orchard is a technology company based in San Francisco that specializes in modernizing and maintaining essential business applications for large enterprises. By leveraging GenAI and advanced software engineering practices, the company focuses on updating legacy computer systems, thereby reducing risks associated with modernization. Mechanical Orchard provides cloud operations as a service, ensuring that businesses can run secure, reliable, and scalable applications. Its mission is to empower clients to remain competitive in a rapidly evolving marketplace, helping them to adapt and thrive amid technological change.

Altana Technologies

Series C in 2024
Altana Technologies operates a global supply chain platform that transforms public and non-public data into an intelligent map of the global supply chain. The platform, known as Altana Atlas, connects enterprises, governments, and logistics providers, facilitating collaboration and trust within business networks. It offers trade data management services by integrating internal and external data to provide clean data sets and a real-time view of transactions, ownership, movements, and risks across the global trade network. By leveraging machine learning, Altana enables organizations in both the public and private sectors to enhance the safety, efficiency, and profitability of trade, while promoting a more resilient, secure, inclusive, and sustainable approach to globalization.

Harvey

Series C in 2024
Harvey is an artificial intelligence technology service provider for knowledge workers. It uses AI to answer legal questions and lands cash from OpenAI. The product provides lawyers with a natural language interface for their existing legal workflow. It offers a unified and intuitive interface for all legal workflows, allowing lawyers to describe tasks in plain English instead of using a suite of complex and specialized tools for niche tasks. Harvey was founded in 2022 and is based in Washington, DC.

Cardurion Pharmaceuticals

Series B in 2024
Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.

Hebbia

Series B in 2024
Hebbia Inc. is a technology company that specializes in developing AI productivity tools tailored for knowledge workers. Established in 2020 and headquartered in West Hollywood, California, Hebbia offers a unique platform designed to facilitate complex task management by transforming prompts into actionable processes completed by AI agents. The platform is utilized by professionals in finance, law, government, and pharmaceuticals, enabling them to handle extensive workflows involving millions of documents. Unlike many AI systems that operate as a black box, Hebbia's technology is transparent, allowing users to verify and collaborate effectively with the AI. It efficiently ingests both structured and unstructured data from various sources, retrieves relevant information upon request, and presents answers in a user-friendly, spreadsheet-like format, thereby supporting comprehensive workflow automation.

Santa Ana Bio

Series B in 2024
Santa Ana Bio is a biotechnology company focused on developing precision therapies for autoimmune and inflammatory diseases. By utilizing advanced technologies such as deep cell profiling, single-cell genomics, and multi-omics platforms, the company designs targeted biologics that aim to provide effective and personalized treatment options. Through its innovative approach, Santa Ana Bio seeks to enhance patient outcomes and improve quality of life for those affected by autoimmune conditions.

StrongDM

Series C in 2024
StrongDM, Inc. is a technology company based in Burlingame, California, founded in 2015. The company offers a platform designed to manage and audit access to various databases and servers for employees, vendors, and cloud-based tools. Its services enable organizations to efficiently create and remove users, manage permissions, and ensure proper data handling. StrongDM's platform simplifies the process of controlling access across multiple systems, enhancing security and compliance. In 2016, the company gained recognition as the Audience Favorite at the Strata+Hadoop World conference, highlighting its impact in the data management sector.

Cerevance

Series B in 2024
Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

Midi Health

Series B in 2024
Midi Health is a virtual care clinic dedicated to addressing the health needs of women, particularly during menopause and related conditions. The clinic specializes in treating issues such as depression, gynecological cancer, and menstrual problems through a clinical platform that delivers personalized care protocols. These protocols are administered by clinicians who are trained in female midlife health. Midi Health enhances its services by utilizing specialized at-home labs, providing prescription medications, supplements, and lifestyle coaching. This comprehensive approach aims to empower women to manage the challenges they face during critical stages of their lives and careers.

Ripcord

Venture Round in 2024
Ripcord, Inc. is a robotic digitization company that specializes in automating the management of paper records. Founded in 2014 and headquartered in Los Angeles, California, Ripcord develops a platform that utilizes advanced technologies, including artificial intelligence, machine learning, and vision-guided robotics, to create digital twins of physical documents. Its flagship solution, Canopy, captures, enriches, and organizes critical content, allowing enterprises to enhance their business processes with improved speed, quality, and accuracy. Formerly known as Ripcord Digital, Inc., the company rebranded in June 2017 to reflect its focus on innovative digitization solutions.

Alethea

Series B in 2024
Alethea is a technology company helping the Fortune 500, private companies and nonprofits protect themselves from harms stemming from disinformation. Leveraging its multi-channel machine learning platform, Artemis, Alethea detects disinformation narratives across the internet, enabling customers to proactively defend against this pervasive threat. With Artemis-powered early detection, Alethea customers can protect their reputations, key assets, physical safety and market value. The company was founded in 2019 and is woman owned.

Oula Health

Series B in 2024
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Accent Therapeutics

Series C in 2024
Accent Therapeutics, Inc. is a biopharmaceutical company based in Lexington, Massachusetts, focused on developing small molecule therapies for oncology through the innovative field of epitranscriptomics. Founded in 2017, the company explores post-transcriptional chemical modifications of RNA, which play a crucial role in regulating proteins essential for cellular growth and differentiation. By precisely targeting RNA-modifying proteins associated with cancer, Accent Therapeutics aims to translate advanced scientific research into effective treatments for patients, ultimately providing new therapeutic options in the fight against cancer.

Comanche Biopharma

Series B in 2024
Comanche Biopharma is a biopharmaceutical company focused on developing an investigational small interfering RNA (siRNA) medicine aimed at treating preterm preeclampsia. The company is committed to ensuring that all women and their babies have access to safe and effective therapies for life-threatening complications during pregnancy. Comanche Biopharma's mission emphasizes the importance of evidence-based and affordable solutions, enabling women to receive cost-effective treatments that address the root causes of preeclampsia.

Lightmatter

Series C in 2023
Lightmatter, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in developing AI hardware using integrated optical technology. The company's core product is a silicon chip that processes data using light signals instead of electrical signals, aiming to significantly accelerate AI computations. Lightmatter targets sectors such as artificial intelligence, cloud computing, and telecommunications, with a focus on improving efficiency and reducing power consumption in critical operations like image recognition and natural language processing.

Seismic Therapeutic

Series B in 2023
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.

Censys

Series C in 2023
Censys, Inc. specializes in internet scanning and asset identification solutions, offering a platform that enables organizations to gain a real-time view of global networks and devices. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides tools for attack surface management, allowing users to discover unknown assets, monitor remote workforces, and identify threat actors. Its internet intelligence platform is designed for threat hunting and exposure management, creating a comprehensive dataset that enhances visibility into vulnerabilities and internet-exposed infrastructure. This enables businesses to efficiently locate and manage the devices, networks, and infrastructure that are critical to their operations.

Signos

Series B in 2023
Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Scope3

Series B in 2023
Scope3 operates a supply chain emissions data platform that provides accurate and comprehensive emissions data to assist companies in integrating sustainability into their business decisions. The company develops models that outline the core inputs and outputs for products and services within the supply chain, enabling organizations to design more sustainable systems. Additionally, Scope3 prepares monthly sustainability reports that offer updated emissions data, allowing businesses to swiftly adapt to external changes and recognize their efforts in reducing carbon footprints.

ROME Therapeutics

Series B in 2023
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

AI21 Labs

Series C in 2023
AI21 Labs, founded in 2017 and based in Tel Aviv-Yafo, Israel, specializes in developing generative artificial intelligence and large language models. The company creates tools designed to enhance the understanding and generation of natural language, effectively transforming how users read and write. Its AI-driven writing companion captures real intelligence, rephrasing text to convey precise meanings while providing summaries that aid in comprehension. These innovations empower users to analyze and visualize complex information more efficiently, facilitating a deeper understanding of abstract knowledge structures. Through the application of deep learning and computer vision algorithms, AI21 Labs aims to significantly improve the efficiency of reading and writing processes.

Modular

Series B in 2023
Modular is an AI software development platform aimed at simplifying the creation and deployment of artificial intelligence applications. The platform integrates various popular frameworks through common interfaces, enhancing usability and flexibility while ensuring compatibility across diverse hardware backends and cloud environments. This approach allows developers to adopt the tools seamlessly into their existing workflows without the need for extensive code modifications. By focusing on production-quality infrastructure and a straightforward user experience, Modular enables developers to save time and increase their productivity, ultimately streamlining the development process from edge to datacenter.

deepset

Series B in 2023
Deepset is a company specializing in natural language processing (NLP) solutions, focusing on leveraging the latest advancements in machine learning to create real-world applications. It is known for developing the Haystack open-source framework, which facilitates the deployment of NLP tasks, and for offering deepset Cloud, a platform designed for enterprise AI teams. Since its inception in 2018, deepset has supported numerous AI teams globally by providing reliable, open-source technology and tailored solutions. The company's software emphasizes the use of transfer learning to enhance model performance while minimizing the amount of training data required, thereby enabling users to unlock value from diverse text sources effectively.

Typeface

Series B in 2023
Typeface is a generative AI application designed for enterprise content creation, facilitating the development of personalized and on-brand materials. The company offers industry-first self-service solutions that streamline the entire content lifecycle, allowing employees to generate high-quality content quickly and efficiently. By combining content velocity with brand personalization and control, Typeface enables organizations to enhance their content production capabilities, ensuring that all generated materials maintain brand authenticity while meeting the demands of speed and creativity. This innovative platform empowers users at all levels to craft captivating content effortlessly.

Runway

Series C in 2023
Runway is an applied AI research company established in 2024, specializing in developing innovative tools that integrate artificial intelligence into creative processes. The company offers a video editing platform designed for professionals in art, entertainment, and design. Its technology leverages original image and video creation methods, allowing users to manipulate and edit content intuitively using text inputs. This approach simplifies the video creation process for artists, designers, and filmmakers, enabling them to express their creativity more effectively. Runway's mission is to enhance human creativity through advanced AI capabilities, facilitating seamless interactions between technology and artistic expression.

Nothing

Series C in 2023
Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. It aims to remove barriers between people and technology by focusing on product integration and user experience. The company offers mobile devices and personalized noise-cancellation earbuds featuring wireless charging, water resistance, and dual connectivity. Through its innovative approach, Nothing seeks to create a seamless digital ecosystem that combines hardware and software, providing customers with reliable and durable technology at affordable prices.

Redpanda Data

Series C in 2023
Redpanda Data is a company that provides a modern streaming data platform designed to handle large data streams effectively. Its platform allows users to record both real-time and historical enterprise data, making it a valuable tool for organizations that require efficient data management. Redpanda's architecture features a compatible application programming interface and is deployable as a single binary, which simplifies the deployment process. Additionally, it includes a built-in schema registry and operates without external dependencies, enhancing performance and reliability for developers. This combination of features enables enterprises to maintain their software stacks while improving data processing capabilities.

Warp

Series B in 2023
Warp is a developer of a Rust-based coding terminal aimed at enhancing productivity in coding and application development. Its software innovatively transforms the traditional command-line interface by dividing the terminal output into a sequence of commands, rather than presenting it as a single buffer. This approach replaces the standard character buffer with a comprehensive text editor, allowing software developers to efficiently navigate, copy, save, and share their work. Warp's terminal redefines the user experience by evolving from a single-user utility into a collaborative platform, where sessions, blocks, and environments are persistent, searchable, and easily shared via links.

Synthesia

Series C in 2023
Synthesia Ltd. is a London-based company that specializes in an artificial intelligence-driven video production platform. Founded in 2017, the company offers a service that transforms text into professional-quality videos featuring customizable avatars and voiceovers in over 140 languages. Its innovative video synthesis technology allows users to create high-end videos for various applications, including personalized advertising, corporate communications, e-learning, and marketing. By synchronizing lip movements with new dialogue tracks, the platform facilitates the translation of video content into different languages, thereby enhancing distribution channels. Users can quickly create, edit, and share studio-quality videos directly in their browser, utilizing fully cloneable AI video templates to streamline production and meet diverse content needs.

Lightmatter

Series C in 2023
Lightmatter, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in developing AI hardware using integrated optical technology. The company's core product is a silicon chip that processes data using light signals instead of electrical signals, aiming to significantly accelerate AI computations. Lightmatter targets sectors such as artificial intelligence, cloud computing, and telecommunications, with a focus on improving efficiency and reducing power consumption in critical operations like image recognition and natural language processing.

Pixxel

Venture Round in 2023
Pixxel is a space data company based in Bengaluru, India, that specializes in manufacturing remote sensing satellites. Founded in 2018, the company develops a constellation of hyperspectral earth imaging satellites capable of capturing geospatial data from every location on the planet. These satellites provide globally accessible, real-time data that can be used for various applications, including climate monitoring, crop yield prediction, urban planning, and disaster response. The constellation is designed to offer global coverage every 24 hours, enabling users to detect, monitor, and predict environmental and economic phenomena. Through its advanced analytical tools, Pixxel aims to support organizations in making informed decisions based on ever-changing data.

AMP

Series C in 2023
AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Clever Care Health Plan

Series C in 2023
Clever Care Health Plan, Inc. is a healthcare insurance provider that specializes in Medicare Advantage plans, integrating the principles of Eastern and Western medicine. Founded in 2018 and headquartered in Westminster, California, with an additional office in Arcadia, the company offers a range of culturally sensitive healthcare solutions. Its plans include access to services such as acupuncture, herbal remedies, tai chi, and cupping, aimed at enhancing both physical and mental well-being. Clever Care connects its members with diverse networks of hospitals and healthcare providers who are attuned to their cultural needs and language preferences. The company distributes its products through brokers and sales agents, ensuring that Medicare beneficiaries receive the support and services they require.

Chroma Medicine

Series B in 2023
Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Aera Therapeutics

Series B in 2023
Aera Therapeutics is a biotechnology company focused on enhancing the delivery of genetic medicines through its proprietary protein nanoparticle (PNP) platform. This innovative platform utilizes endogenous human proteins to create capsid-like structures that can effectively package and transfer nucleic acid cargo. By addressing the limitations of current delivery technologies, Aera aims to extend the application of genetic medicines across various tissues and disease areas, ultimately benefiting a wider patient population. In addition to its PNP platform, Aera has developed a therapeutic enzyme platform that features novel, compact, and programmable gene-editing enzymes, further advancing its mission to transform the field of genetic medicine.

Cerevance

Series B in 2023
Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

Mill

Venture Round in 2023
Mill is a company focused on addressing food waste, a significant environmental challenge. It offers innovative kitchen bins that dry, shrink, and eliminate odors from leftover food, transforming waste into a compost-like material. These digitally connected bins can be rented, allowing users to efficiently manage their kitchen waste overnight. Additionally, Mill facilitates the shipping of the processed material to facilities that convert it into animal feed, thereby promoting a sustainable waste management system. Through its products and services, Mill aims to contribute to a healthier environment by providing practical solutions for reducing food waste at home.

Oxa

Series C in 2023
Oxa is a developer of autonomous vehicle software that focuses on creating AI-based platforms for the operation and scaling of fleets of autonomous vehicles. The company's technology combines laser vision and radar for effective localization, allowing autonomous systems to understand their surroundings and navigate safely in complex environments. Oxa's software is designed to operate with low compute power requirements, making it accessible for various business applications. By providing solutions that enhance vehicle positioning and movement prediction, Oxa enables clients to implement and accelerate the deployment of autonomous vehicles in a range of settings.

Chronosphere

Venture Round in 2023
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Carrick Therapeutics

Series C in 2022
Carrick Therapeutics, Ltd., established in 2015 and headquartered in Dublin, Ireland, focuses on developing innovative cancer therapeutics aimed at transforming cancer treatment. The company targets molecular pathways associated with aggressive and resistant forms of cancer, employing advanced mechanisms to improve treatment outcomes. By enabling the detection of predictive biomarkers, Carrick Therapeutics facilitates the initiation of targeted therapies at early stages, ultimately striving to enhance the lives of cancer patients.

Pangea

Series B in 2022
Pangea is a developer of security APIs that offers a comprehensive portfolio of security services tailored for application builders. The company provides a single platform that simplifies the integration of security into cloud and mobile applications. Pangea's services are designed to be globally accessible while maintaining regional intelligence, making them suitable for diverse markets. Available on major cloud platforms such as AWS and GCP, Pangea enables clients—including app developers, SaaS providers, and security operations teams—to efficiently create secure and compliant user experiences. The company aims to make security accessible to all developers, eliminating the need for extensive security expertise.

Dandelion Energy

Series B in 2022
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

AMP

Series C in 2022
AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Landis

Series B in 2022
Landis is an online real estate platform founded in 2018 and headquartered in New York, NY, that focuses on helping renters become homeowners. The company allows clients to choose their dream home, rent it, and purchase it within the first twelve months. In addition to facilitating this transition, Landis provides tools and incentives designed to assist clients in improving their credit scores and accumulating down payment savings. With a commitment to transparency and simplicity, Landis aims to create a seamless process for renters to transition to homeownership. The company also specializes in commercial real estate technology and residential offerings.

Progcap

Series C in 2022
Progcap is a financial service company based in New Delhi, India, that focuses on providing financial opportunities for micro and small businesses, particularly in semi-urban and rural areas. Founded in 2017, the company employs a technology-driven approach to assess the creditworthiness of businesses through non-traditional ecosystem data, allowing it to create tailored credit scores for customers who are often overlooked by conventional financial institutions. By offering flexible, collateral-free working capital, Progcap aims to empower these businesses with affordable and timely credit solutions. Additionally, the company provides finance and supply chain-based services designed to support the growth and sustainability of micro and small enterprises in India.

Altana Technologies

Series B in 2022
Altana Technologies operates a global supply chain platform that transforms public and non-public data into an intelligent map of the global supply chain. The platform, known as Altana Atlas, connects enterprises, governments, and logistics providers, facilitating collaboration and trust within business networks. It offers trade data management services by integrating internal and external data to provide clean data sets and a real-time view of transactions, ownership, movements, and risks across the global trade network. By leveraging machine learning, Altana enables organizations in both the public and private sectors to enhance the safety, efficiency, and profitability of trade, while promoting a more resilient, secure, inclusive, and sustainable approach to globalization.

Adda247

Series B in 2022
Adda247 is an edtech platform based in Gurugram, India, specializing in the preparation for government examinations. Founded in 2010, the company provides a comprehensive learning ecosystem that includes online courses, study materials, and test series for various competitive exams. As a subsidiary of Metis Eduventures Private Limited, Adda247 aims to empower students with the resources needed to succeed in their academic and career pursuits in the public sector. The platform leverages technology to deliver accessible and effective educational solutions, making it a prominent player in the Indian education landscape.

Flatfile

Series B in 2022
Flatfile Inc. is a company that specializes in data onboarding solutions, enabling developers to efficiently validate, map, and import CSV data from various web applications. Founded in 2018 and based in Denver, Colorado, Flatfile offers a platform that integrates seamlessly with software applications, allowing users to upload data through formats such as CSV, XLS, or TSV. Its key products include Portal, which provides an import button embedded via a JavaScript snippet, and Concierge, which creates secure collaborative workspaces for organizations to manage complex data ingestion challenges. The platform is designed to enhance developer productivity, reduce costs, and improve data quality by learning to identify and clean incoming data over time. Numerous companies, including AstraZeneca and Square, utilize Flatfile’s API-first platform to streamline their data import processes.

SpinLaunch

Series B in 2022
SpinLaunch Inc. is a spaceflight technology development company based in Long Beach, California, founded in 2014. The company is focused on creating an innovative launch system that utilizes a large mass accelerator, or centrifuge, to propel payloads into space without the use of chemical propellants. This kinetic space launch system is designed to enable on-demand launches of small satellites in various weather conditions. By spinning the payload in a vacuum to minimize friction, SpinLaunch aims to achieve speeds of approximately 3,000 miles per hour. This method allows for a more cost-effective and sustainable approach to space travel, as the system can either launch payloads directly into space or assist them with supplemental rockets to exit Earth's atmosphere.

Sardine

Series B in 2022
Sardine is a financial technology company that specializes in providing a risk and fraud infrastructure tailored for the online economy. It has developed a device intelligence platform that leverages artificial intelligence and advanced risk engine software. This platform enhances fraud detection while minimizing sign-up friction by analyzing multiple real-time data points, including device information, browser details, and behavioral biometrics. By integrating this technology, Sardine enables businesses to establish a robust risk and fraud management framework, ultimately reducing costs within the fintech ecosystem.

Vitara Biomedical

Series B in 2022
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Isovalent

Series B in 2022
Isovalent, Inc. specializes in developing software solutions for enterprises to connect, monitor, and secure workloads in cloud-native environments. The company's flagship product, Cilium, leverages eBPF to enhance networking, security, and observability for Kubernetes deployments across both cloud and on-premises infrastructures. Isovalent offers Cilium Enterprise, which focuses on security automation, compliance, and integration with legacy systems, along with open-source tools that facilitate network connectivity, threat detection, and security compliance monitoring. Founded by the creators of Cilium and eBPF, Isovalent serves a diverse clientele, including major organizations like Adobe, AWS, and Google. The company was established in 2016 and has its headquarters in Cupertino, California, with an additional office in Zurich, Switzerland.

Kindbody

Venture Round in 2022
Kindbody is a comprehensive fertility clinic network and family-building benefits provider that offers a wide range of services aimed at improving access to healthcare for women. The company provides both virtual and in-person care, including fertility assessments, education, preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. By partnering with employers, Kindbody delivers financial, medical, and emotional support to employees pursuing parenthood. The company serves more than 100 employers, covering over 2.4 million lives, while also providing direct fertility care through its network of signature clinics, mobile clinics, and partner clinics across the country. With a focus on affordability and accessibility, Kindbody employs modern technology to deliver holistic health and fertility services.

Lori Systems

Series B in 2022
Lori Systems is a logistics platform based in Nairobi, Kenya, that connects transporters with cargo owners across Africa. Founded in 2016, the company also has offices in Mombasa, Uganda, and Lagos. Lori addresses a significant challenge in the African logistics sector, where up to 75% of product costs can be attributed to logistics, compared to only 6% in the United States. The platform provides a tech-enabled and operations-driven marketplace that enhances transparency, flexibility, reliability, and cost efficiency, achieving savings of over 18% for users. It offers real-time tracking of cargo, automated documentation, and streamlined payment processes, facilitating smoother goods transportation across the continent. Since its product launch in May 2017, Lori has experienced rapid growth, with a compounded monthly increase of 30%. The demand for its services continues to rise, supported by recent investments from prominent institutional and strategic investors. The company has also received recognition, including winning Techcrunch Battlefield Africa.

Merlin Labs

Series B in 2022
Merlin Labs is an innovative company focused on creating autonomous flight technology for advanced air travel, primarily utilizing fixed-wing aircraft. Founded in 2018 and headquartered in Boston, Massachusetts, the company develops a sophisticated aircraft autonomy system that employs artificial intelligence and machine learning, akin to the technology used in driverless cars. This system aims to facilitate the pilotless transportation of goods and eventually people, establishing a new infrastructure for aerial mobility.

Progcap

Series C in 2022
Progcap is a financial service company based in New Delhi, India, that focuses on providing financial opportunities for micro and small businesses, particularly in semi-urban and rural areas. Founded in 2017, the company employs a technology-driven approach to assess the creditworthiness of businesses through non-traditional ecosystem data, allowing it to create tailored credit scores for customers who are often overlooked by conventional financial institutions. By offering flexible, collateral-free working capital, Progcap aims to empower these businesses with affordable and timely credit solutions. Additionally, the company provides finance and supply chain-based services designed to support the growth and sustainability of micro and small enterprises in India.

Medallion

Series C in 2022
Medallion is a company that offers a network management platform tailored for the healthcare industry, focusing on simplifying the complex processes of licensing, credentialing, and payer enrollment. Founded in 2020 by Derek Lo and based in San Francisco, California, Medallion's all-in-one platform addresses the logistical challenges that healthcare providers and telemedicine companies face, enabling them to minimize time spent on administrative tasks. Key features of the platform include facilities for new licensing and renewals, primary source verification, continuing medical education tracking, and document management. By streamlining these processes, Medallion allows healthcare professionals to concentrate more on patient care rather than paperwork.

Courier

Series B in 2022
Courier provides a notification management platform that allows developers to effectively route user notifications across various communication channels, such as email, SMS, and messaging apps. By utilizing an API, the platform intelligently determines the optimal channel for delivering messages based on user engagement and online status. This capability enables businesses to craft a single message that can be reused across multiple channels or customized for specific platforms, ensuring timely and relevant communication with users, business partners, and external stakeholders. With a commitment to customer success, Courier has evolved alongside technological advancements while maintaining stable management practices and long-term relationships with its clients.

Sesame

Series B in 2022
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

Wonder

Series B in 2022
Wonder is a technology company that specializes in gaming and food delivery services. It offers an all-in-one gaming platform for Android mobile devices, enabling users to play, stream, and share games across various devices. Additionally, Wonder operates a food delivery service using trucks that function as mobile restaurants. Customers order food through a mobile app, and the Wonder trucks drive to a location near the user's home to prepare and deliver fresh meals on-site.

Nava

Series B in 2022
Nava is a health insurance brokerage based in New York, New York, dedicated to providing high-quality, affordable healthcare solutions to employers and their employees. The company offers a range of services that include healthcare tools, year-round employee advocacy, and continuous evaluation of healthcare plans. By leveraging these resources, Nava empowers clients to deliver essential benefits while simultaneously reducing overall plan costs. Its innovative approach aims to transform the employee benefits landscape through enhanced access and advocacy in healthcare.

FarmWise

Series B in 2022
FarmWise, established in 2016 and headquartered in San Francisco, specializes in developing and manufacturing robotic machinery for agriculture. The company's primary product is a mechanical weeder, designed to efficiently remove weeds and thin crops, thereby enhancing agricultural productivity. FarmWise also provides comprehensive training and support to ensure the effective use of its technology.

Gametime

Venture Round in 2022
Gametime is a mobile platform that specializes in selling last-minute tickets for a variety of live events, including sports, concerts, and theater, across the United States and Canada. The service simplifies the ticket purchasing process by curating a selection of the best available options from over 10,000 seats, allowing clients to choose from 50 top values. Each ticket option is accompanied by a high-resolution panoramic photo, providing users with a preview of the view from their chosen section. The platform features interactive seat maps that allow for easy comparison of prices and locations, enhancing the customer experience. Tickets are conveniently delivered directly to the user's phone, facilitating instant access to entertainment.

Mirvie

Series B in 2022
Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.

Invetx

Series B in 2022
Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.

Aspen Neuroscience

Series B in 2022
Aspen Neuroscience, Inc. is a biotechnology company focused on developing induced pluripotent stem cells (iPSCs) to create patient-specific therapies for neurological conditions, particularly Parkinson's disease. Founded in 2018 and based in San Diego, California, the company is advancing its pipeline of products, which includes ANPD001, an autologous neuron replacement therapy for sporadic Parkinson's disease, and ANPD002, a gene-edited autologous neuron replacement therapy targeting familial forms of the disease. Aspen Neuroscience employs innovative genomic approaches in conjunction with stem cell biology to address diseases with significant unmet medical needs, aiming to provide restorative cell therapies that can modify the progression of Parkinson's disease and potentially extend to other affected organs.

OMass Therapeutics

Series B in 2022
OMass Therapeutics Limited is a biotechnology company based in Oxford, United Kingdom, established in 2016. The company specializes in drug discovery, utilizing structural mass spectrometry technology to develop innovative therapeutics aimed at difficult disease targets. Its platform allows clients to access native mass spectrometry without the need for sophisticated instrumentation or in-house expertise. This capability enables the study of complex protein assemblies and their interactions with other biological molecules, facilitating the development of drugs and biotherapeutics. OMass Therapeutics aims to provide a dynamic and collaborative environment for biotechnology and pharmaceutical clients to address challenging drug targets effectively.

Obsidian Security

Series C in 2022
Obsidian Security, Inc. develops cloud infrastructure and data center security solutions, focusing on cybersecurity and artificial intelligence to address cyber threats in hybrid-cloud environments. The company provides a platform that enables threat detection, breach remediation, and security hardening specifically for business-critical software as a service (SaaS) applications. By delivering cloud detection and response capabilities, Obsidian Security aims to enhance the security posture of enterprises. Founded in 2017 and headquartered in Newport Beach, California, the company is dedicated to creating a comprehensive understanding of interconnected applications to ensure their safety and security.

Brightline

Series C in 2022
Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.

Celsius Therapeutics

Series B in 2022
Celsius Therapeutics is a biotechnology company focused on developing precision medicines for patients with cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a team of scientists, technologists, computational biologists, clinicians, and drug hunters. Utilizing single-cell genomic analysis and machine learning techniques, Celsius Therapeutics aims to discover and create innovative therapies that can lead to significant improvements in patient outcomes. The company's research efforts are centered on identifying new drug candidates that address unmet medical needs in the therapeutic landscape.

Digits

Series C in 2022
Digits Financial, Inc. is a fintech company founded in 2018 and based in San Francisco, California. The company specializes in developing software that offers a real-time view of a business's finances. Its platform streamlines the creation of financial reports and transaction records, significantly reducing manual workload. By visualizing and managing financial data, Digits enhances interactions between businesses and their accountants, investors, and advisors. This innovative approach positions Digits as a key player in providing modern financial solutions for businesses.

LifeMine Therapeutics

Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

Spotlight Therapeutics

Series B in 2022
Spotlight Therapeutics, Inc. specializes in the development of gene editing therapeutics designed to target specific cell populations directly within the body. Established in 2017 and based in Hayward, California, the company leverages a biotechnology platform that utilizes CRISPR nuclease effectors for in vivo gene editing. Its innovative approach aims to create next-generation programmable nucleases that enhance treatment options for a variety of conditions. Spotlight Therapeutics is focused on multiple therapeutic areas, including immuno-oncology, ophthalmology, and hematology, and is developing programs to address previously undruggable intracellular gene targets as well as specific monogenic disease targets related to the eye. This targeted gene editing strategy seeks to overcome the challenges associated with traditional delivery methods, thereby providing healthcare providers with improved tools for patient treatment.

Nothing

Series B in 2022
Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. It aims to remove barriers between people and technology by focusing on product integration and user experience. The company offers mobile devices and personalized noise-cancellation earbuds featuring wireless charging, water resistance, and dual connectivity. Through its innovative approach, Nothing seeks to create a seamless digital ecosystem that combines hardware and software, providing customers with reliable and durable technology at affordable prices.

Redpanda Data

Series B in 2022
Redpanda Data is a company that provides a modern streaming data platform designed to handle large data streams effectively. Its platform allows users to record both real-time and historical enterprise data, making it a valuable tool for organizations that require efficient data management. Redpanda's architecture features a compatible application programming interface and is deployable as a single binary, which simplifies the deployment process. Additionally, it includes a built-in schema registry and operates without external dependencies, enhancing performance and reliability for developers. This combination of features enables enterprises to maintain their software stacks while improving data processing capabilities.

RightHand Robotics

Series C in 2022
RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

Genesis Global

Series C in 2022
Genesis Global Technology Limited specializes in developing custom software and solutions tailored for the capital markets. Founded in 2015 and headquartered in London, with an additional office in New York, the company provides a range of platforms designed to enhance trading and operational efficiency. Its offerings include an automated quoting system for managing requests for quotes, an order execution management system, and a trade allocation manager that facilitates various trading processes. Additionally, Genesis Global offers tools for data management and reconciliation, such as a short/long code manager and a matcher. The company is led by a team of industry veterans with substantial experience in trading technologies across multiple asset classes, aiming to deliver innovative solutions that align with the evolving needs of clients in the financial sector.

Homebound

Series C in 2022
Homebound Inc. is a technology-driven custom home builder based in Santa Rosa, California, founded in 2017. The company specializes in constructing residential homes and offers a comprehensive range of support services, including architecture, design, financing, and insurance consultancy. Originating in response to the 2017 Northern California wildfires, Homebound aims to simplify the homebuilding process by providing a transparent and streamlined experience for homeowners. It manages the entire building journey, assisting clients from insurance negotiation and architectural design to permitting and construction. By leveraging user-friendly technology and a network of qualified building professionals, Homebound addresses the complexities and uncertainties homeowners face, particularly in the aftermath of natural disasters, enabling them to rebuild their homes more efficiently.

Ventus Therapeutics

Series C in 2022
Ventus Therapeutics is a biopharmaceutical company focused on discovering and developing novel small molecule medicines aimed at treating autoimmune diseases, inflammatory diseases, and cancer by targeting the innate immune system. The company employs a structural immunology platform that provides deep insights into the mechanisms and molecular structures involved in immune responses. This platform integrates proprietary protein engineering capabilities with advanced rational and structure-based drug design tools, allowing for precise targeting of the innate immune system. Ventus is actively building a pipeline of drug programs that address critical targets within this system, particularly proteins involved in inflammasome and nucleic acid-sensing signaling pathways, thereby enabling the treatment of both acute and chronic inflammatory and immune-related conditions.

Pecan

Series C in 2022
Pecan operates a predictive analytics platform that empowers businesses to forecast critical outcomes effectively. It utilizes a low-code interface that simplifies the predictive modeling process, allowing companies to generate accurate predictions without needing in-house data scientists or engineers. Pecan automates data preparation and feature engineering, enabling users, particularly SQL-trained business intelligence analysts, to create tailored predictive models quickly. The platform supports various industries, including fintech, insurance, retail, and consumer services, by providing pre-built models and templates that align with specific business objectives. This capability allows organizations to enhance customer lifetime value, retention, conversion rates, and demand forecasting. Pecan's solutions have a significant financial impact, influencing billions of dollars in revenue across various sectors.

Censys

Series B in 2022
Censys, Inc. specializes in internet scanning and asset identification solutions, offering a platform that enables organizations to gain a real-time view of global networks and devices. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides tools for attack surface management, allowing users to discover unknown assets, monitor remote workforces, and identify threat actors. Its internet intelligence platform is designed for threat hunting and exposure management, creating a comprehensive dataset that enhances visibility into vulnerabilities and internet-exposed infrastructure. This enables businesses to efficiently locate and manage the devices, networks, and infrastructure that are critical to their operations.

InstaDeep

Series B in 2022
InstaDeep Ltd is a company that specializes in developing artificial intelligence-based decision-making systems for the enterprise sector. Founded in 2014 and headquartered in London, the company also has offices in Paris, Tunis, Nairobi, and Lagos. InstaDeep's platform is designed to enhance talent retention and training while providing a range of AI programs. These include optimized pattern recognition, GPU-accelerated insights, self-learning systems, machine learning, and predictive analytics. By utilizing these technologies, InstaDeep enables businesses to improve efficiencies in manufacturing, logistics, mobility, and energy, ultimately leading to increased return on investments.

Leyden Labs

Series B in 2022
Leyden Labs is a biotechnology company focused on developing intranasal products aimed at protecting individuals from respiratory viruses. By targeting commonalities among various viral families, Leyden Labs seeks to provide broad-spectrum protection against multiple strains of viruses, including those in the influenza and coronavirus families. Unlike traditional vaccines that typically address specific variants, Leyden Labs' innovative approach allows for simultaneous protection against a range of viruses, thereby empowering individuals to safeguard their health and prevent the transmission of diseases. The company's team comprises experienced biotechnology professionals and new talent, all committed to advancing solutions that alleviate the impact of respiratory infections on global health.

Sibros

Series B in 2022
Sibros specializes in software-defined vehicle technology through its Deep Connected Platform™, which integrates real-time data collection, software configuration management, remote updates, and diagnostic commands. This platform adheres to essential automotive safety, security, and data privacy standards, making it adaptable for various vehicle architectures, including legacy gas and diesel models, next-generation battery electric vehicles, fuel cells, motorcycles, buses, commercial trucks, and heavy machinery. The company's innovative technology, developed in Silicon Valley, allows original equipment manufacturers (OEMs) to enhance customer experiences, achieve cost efficiencies, and explore new revenue models throughout the mobility product life cycle. Sibros' solutions enable automakers to manage their vehicle software inventory, configurations, and updates while providing insights through extensive vehicle analytics and remote command capabilities.

Mill

Series B in 2022
Mill is a company focused on addressing food waste, a significant environmental challenge. It offers innovative kitchen bins that dry, shrink, and eliminate odors from leftover food, transforming waste into a compost-like material. These digitally connected bins can be rented, allowing users to efficiently manage their kitchen waste overnight. Additionally, Mill facilitates the shipping of the processed material to facilities that convert it into animal feed, thereby promoting a sustainable waste management system. Through its products and services, Mill aims to contribute to a healthier environment by providing practical solutions for reducing food waste at home.

Found

Series B in 2021
Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.